215 related articles for article (PubMed ID: 11747231)
1. Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.
Chhieng DC; Ko EC; Yee HT; Shultz JJ; Dorvault CC; Eltoum IA
Diagn Cytopathol; 2001 Dec; 25(6):356-60. PubMed ID: 11747231
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma.
Liu J; Farhood A
Acta Cytol; 2004; 48(5):635-40. PubMed ID: 15471255
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
Tamiolakis D; Papadopoulos N; Cheva A; Lambropoulou M; Kotini A; Mikroulis D; Didilis V; Bitzikas N; Bougioukas G
Minerva Med; 2002 Dec; 93(6):479-83. PubMed ID: 12515971
[TBL] [Abstract][Full Text] [Related]
4. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
5. Vimentin and leukocyte common antigen-negative molding cells in pleural effusions of patients with small cell lung carcinoma.
Cao QJ; Panetti C; Marconi S; Krebs P; Lorenzana RR; Goulart RA; Bur ME
Acta Cytol; 2003; 47(6):1033-7. PubMed ID: 14674074
[TBL] [Abstract][Full Text] [Related]
6. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S
Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820
[TBL] [Abstract][Full Text] [Related]
8. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.
Lew M; Pang JC; Roh MH; Jing X
Acta Cytol; 2015; 59(5):412-7. PubMed ID: 26587773
[TBL] [Abstract][Full Text] [Related]
9. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
Ordóñez NG
Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
[TBL] [Abstract][Full Text] [Related]
10. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
11. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
12. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
13. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.
Nicholson SA; Beasley MB; Brambilla E; Hasleton PS; Colby TV; Sheppard MN; Falk R; Travis WD
Am J Surg Pathol; 2002 Sep; 26(9):1184-97. PubMed ID: 12218575
[TBL] [Abstract][Full Text] [Related]
14. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
15. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
[TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
17. Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis.
Wiatrowska BA; Krol J; Zakowski MF
Diagn Cytopathol; 2001 Jan; 24(1):58-64. PubMed ID: 11135471
[TBL] [Abstract][Full Text] [Related]
18. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201
[TBL] [Abstract][Full Text] [Related]
19. EZH2, a unique marker of malignancy in effusion cytology.
Jiang H; Gupta R; Somma J
Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
[TBL] [Abstract][Full Text] [Related]
20. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
